연구동향 분석

The Role of Insulin Resistance in Diabetic Neuropathy in Koreans with Type 2 Diabetes Mellitus: A 6-Year Follow-Up Study

조유나 최영철 이기욱 정주리 박형준 김승민 신하영 홍지만 안철우 2014년

논문상세정보
인용/피인용
' The Role of Insulin Resistance in Diabetic Neuropathy in Koreans with Type 2 Diabetes Mellitus: A 6-Year Follow-Up Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • diabetic neuropathy
  • insulin resistance
  • metabolic syndrome
  • type 2 diabetes mellitus
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,173 0

0.0%

' The Role of Insulin Resistance in Diabetic Neuropathy in Koreans with Type 2 Diabetes Mellitus: A 6-Year Follow-Up Study' 의 참고문헌

  • Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity
    Gelding SV Clin Endocrinol (Oxf) 40 : 611 ~ 615 [1994]
  • Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity
    Gelding SV Clin Endocrinol (Oxf) 40 611-615 [1994]
  • The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus
    Karsidag S Diabetes Res Clin Pract 67 : 211 ~ 219 [2005]
  • The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus
    Karsidag S Diabetes Res Clin Pract 67 211-219 [2005]
  • The developmental origins, mechanisms, and implications of metabolic syndrome
    Bruce KD J Nutr 140 : 648 ~ 652 [2010]
  • The developmental origins, mechanisms, and implications of metabolic syndrome
    Bruce KD J Nutr 140 648-652 [2010]
  • The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia
    Fruchart JC Am J Cardiol 102 (10 Su) : 1K ~ 34K [2008]
  • The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia
    Fruchart JC Am J Cardiol 102 10 Su 1K-34K [2008]
  • Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes
    Woo V Int J Clin Pract 62 : 1935 ~ 1942 [2008]
  • Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes
    Woo V Int J Clin Pract 62 1935-1942 [2008]
  • Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?
    Albers JW Diabetes Care 30 : 2613 ~ 2618 [2007]
  • Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?
    Albers JW Diabetes Care 30 2613-2618 [2007]
  • Standards of medical care in diabetes--2012
    American Diabetes Association Diabetes Care 35 (Suppl 1) : S11 ~ S63 [2012]
  • Standards of medical care in diabetes--2012
    American Diabetes Association Diabetes Care 35 Suppl 1 S11-S63 [2012]
  • Report of the expert committee on the diagnosis and classification of diabetes mellitus
  • Report of the expert committee on the diagnosis and classification of diabetes mellitus
  • Potential risk factors for diabetic neuropathy: a case control study
    Booya F BMC Neurol 5 : 24 ~ [2005]
  • Potential risk factors for diabetic neuropathy: a case control study
    Booya F BMC Neurol 5 24- [2005]
  • NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy
    Bril V Eur Neurol 41 (Suppl 1) : 8 ~ 13 [1999]
  • NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy
    Bril V Eur Neurol 41 Suppl 1 8-13 [1999]
  • Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes
    Dyck PJ Diabetes Care 29 : 2282 ~ 2288 [2006]
  • Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes
    Dyck PJ Diabetes Care 29 2282-2288 [2006]
  • Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    Nathan DM Diabetes Care 32 : 193 ~ 203 [2009]
  • Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    Nathan DM Diabetes Care 32 193-203 [2009]
  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Inzucchi SE Diabetologia 55 : 1577 ~ 1596 [2012]
  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Inzucchi SE Diabetologia 55 1577-1596 [2012]
  • Is mitochondrial dysfunction a cause of insulin resistance?
    Turner N Trends Endocrinol Metab 19 : 324 ~ 330 [2008]
  • Is mitochondrial dysfunction a cause of insulin resistance?
    Turner N Trends Endocrinol Metab 19 324-330 [2008]
  • Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients.
    Lee KO ACTA DIABETOLOGICA 49 (2) : 97 ~ 103 [2012]
  • Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients.
    Lee KO ACTA DIABETOLOGICA 49 2 97-103 [2012]
  • Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy
    Smith AG J Peripher Nerv Syst 17 (Suppl 2) : 15 ~ 21 [2012]
  • Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy
    Smith AG J Peripher Nerv Syst 17 Suppl 2 15-21 [2012]
  • Hyperlipidemia: a new therapeutic target for diabetic neuropathy
    Vincent AM J Peripher Nerv Syst 14 : 257 ~ 267 [2009]
  • Hyperlipidemia: a new therapeutic target for diabetic neuropathy
    Vincent AM J Peripher Nerv Syst 14 257-267 [2009]
  • Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons
    Kim B Endocrinology 152 : 3638 ~ 3647 [2011]
  • Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons
    Kim B Endocrinology 152 3638-3647 [2011]
  • Gender differences in the onset of diabetic neuropathy
    Aaberg ML J Diabetes Complications 22 : 83 ~ 87 [2008]
  • Gender differences in the onset of diabetic neuropathy
    Aaberg ML J Diabetes Complications 22 83-87 [2008]
  • Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy
    Dyck PJ Ann Neurol 19 : 425 ~ 439 [1986]
  • Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy
    Dyck PJ Ann Neurol 19 425-439 [1986]
  • Etiology of insulin resistance
    Petersen KF Am J Med 119 (5 Suppl 1) : S10 ~ S16 [2006]
  • Etiology of insulin resistance
    Petersen KF Am J Med 119 5 Suppl 1 S10-S16 [2006]
  • Elevated glycosylated hemoglobin is associated with subclinical neuropathy in neurologically asymptomatic diabetic patients: a prospective study
    El-Salem K J Clin Neurophysiol 26 : 50 ~ 53 [2009]
  • Elevated glycosylated hemoglobin is associated with subclinical neuropathy in neurologically asymptomatic diabetic patients: a prospective study
    El-Salem K J Clin Neurophysiol 26 50-53 [2009]
  • Dyslipidemia-induced neuropathy in mice:the role of oxLDL/LOX-1
    Vincent AM Diabetes 58 : 2376 ~ 2385 [2009]
  • Dyslipidemia-induced neuropathy in mice:the role of oxLDL/LOX-1
    Vincent AM Diabetes 58 2376-2385 [2009]
  • Distal symmetric polyneuropathy:a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
    England JD Neurology 64 199-207 [2005]
  • Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
    England JD Neurology 64 : 199 ~ 207 [2005]
  • Diabetic neuropathy--a review
    Said G Nat Clin Pract Neurol 3 : 331 ~ 340 [2007]
  • Diabetic neuropathy--a review
    Said G Nat Clin Pract Neurol 3 331-340 [2007]
  • Conduction block in diabetic neuropathy
    Abu-Shakra SR Muscle Nerve 14 : 858 ~ 862 [1991]
  • Conduction block in diabetic neuropathy
    Abu-Shakra SR Muscle Nerve 14 858-862 [1991]
  • Clinical characteristics of Korean type 2 diabetic patients in 2005
    Kim DJ Diabetes Res Clin Pract 77 (Suppl 1) : S252 ~ S257 [2007]
  • Clinical characteristics of Korean type 2 diabetic patients in 2005
    Kim DJ Diabetes Res Clin Pract 77 Suppl 1 S252-S257 [2007]
  • Assessment of the medial dorsal cutaneous, dorsal sural, and medial plantar nerves in impaired glucose tolerance and diabetic patients with normal sural and superficial peroneal nerve responses
    Im S Diabetes Care 35 : 834 ~ 839 [2012]
  • Assessment of the medial dorsal cutaneous, dorsal sural, and medial plantar nerves in impaired glucose tolerance and diabetic patients with normal sural and superficial peroneal nerve responses
    Im S Diabetes Care 35 834-839 [2012]
  • Animal models of peripheral neuropathies
    Höke A Neurotherapeutics 9 : 262 ~ 269 [2012]
  • Animal models of peripheral neuropathies
    Höke A Neurotherapeutics 9 262-269 [2012]
  • Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy
    Viader A Neuron 77 : 886 ~ 898 [2013]
  • Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy
    Viader A Neuron 77 886-898 [2013]
  • A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy
    Feldman EL Diabetes Care 17 : 1281 ~ 1289 [1994]
  • A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy
    Feldman EL Diabetes Care 17 1281-1289 [1994]